The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Market Value Expansion Is Expected For The Jynneos Market Over The Forecast Period?
The expansion seen historically was primarily due to global campaigns aimed at eradicating smallpox, previous instances of monkeypox outbreaks, the creation of more secure vaccinia platforms, government-led preparedness schemes, and general public health vaccination drives.
The expansion anticipated during the forecast period is primarily driven by escalating risks associated with zoonotic diseases, the enlargement of national vaccine stockpiles, increased financial support for biodefense, enhanced global surveillance networks, and the implementation of more extensive adult vaccination programs. Furthermore, significant trends observed in the same forecast period involve a heightened emphasis on the prevention of emerging infectious diseases, the proliferation of non-replicating vaccine technologies, an expansion in government-led immunization initiatives, the increased stockpiling of strategic vaccines, and a growing public awareness of zoonotic illnesses.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20118&type=smp
Which Significant Factors Are Encouraging Growth In The Jynneos Market?
The jynneos market is projected to grow due to the increasing occurrence of monkeypox cases. Monkeypox, a viral illness caused by the monkeypox virus belonging to the orthopoxvirus family, sees a rise in cases attributed to increased global travel and more significant human-wildlife interactions, which facilitate the rapid spread of infectious agents beyond isolated outbreaks. Jynneos is effective against monkeypox as it provides robust viral prevention for at-risk individuals and is considered safer for those with weakened immune systems compared to traditional smallpox vaccines. For example, in September 2024, the European Centre for Disease Prevention and Control, a Europe-based government agency, reported over 100,000 confirmed cases of pox due to monkeypox virus (MPXV) clade I and clade II, including more than 200 deaths, across over 120 countries globally between January 2022 and July 2024. This increase in monkeypox cases is therefore a primary factor driving the expansion of the Jynneos market.
Jynneos Market Driver: Development Of Combined Vaccines To Enhance Public Health Preparedness
Key companies within the jynneos market are concentrating on developing combined vaccines to simultaneously target multiple diseases. Combined vaccines are immunizations that offer protection against several illnesses with a single injection, thereby reducing the number of shots needed for complete immunization. For instance, in August 2024, Bavarian Nordic A/S, a Denmark-based biotechnology company, announced that Singapore’s Health Sciences Authority (HSA) had approved JYNNEOS (MVA-BN) for preventing smallpox and pox in adults aged 18 and older who are at high risk for these infections. JYNNEOS (MVA-BN) is a non-replicating vaccine specifically designed to be a safer alternative for individuals, including those who are immunocompromised. Its development aims to bolster public health preparedness and address emerging infectious diseases effectively.
What Segment Categories Are Evaluated In The Jynneos Market Study?
The jynneos market covered in this report is segmented –
1) By Indication: Prevention of Monkeypox, Prevention of Smallpox
2) By Formulation: Injectable Formulation, Lyophilized Powder for Reconstitution
3) By Patient Demographics: Adult Patients, Pediatric Patients, High-Risk Populations
4) By Distribution channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Specialty Clinics, Public Health Organizations, Home Healthcare Providers
Who Are The Key Market Participants In The Jynneos Market?
Major companies operating in the jynneos market are Bavarian Nordic A/S
Access The Complete Jynneos Market Report:
https://www.thebusinessresearchcompany.com/report/jynneos-global-market-report
Which Region Has The Strongest Presence In The Jynneos Market?
North America was the largest region in the jynneos market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the jynneos market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model